Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of FREDUN PHARMA. For more details, see the FREDUN PHARMA quarterly results and FREDUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 8.5 |
No. of shares | m | 4.72 |
1 Week | % | 6.0 |
1 Month | % | 15.4 |
1 Year | % | -6.8 |
52 week H/L | Rs | 1,249.0/650.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
FREDUN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 495 | 500 | 597 | 1,140 | 1,428 | |
Low | Rs | 143 | 103 | 113 | 351 | 675 | |
Sales per share (Unadj.) | Rs | 243.1 | 282.6 | 335.6 | 506.7 | 606.3 | |
Earnings per share (Unadj.) | Rs | 11.2 | 4.8 | 5.1 | 14.3 | 23.9 | |
Diluted earnings per share | Rs | 9.4 | 4.0 | 4.3 | 13.4 | 22.9 | |
Cash flow per share (Unadj.) | Rs | 14.5 | 9.5 | 10.1 | 19.2 | 30.1 | |
Dividends per share (Unadj.) | Rs | 0.65 | 0.66 | 0.70 | 0.70 | 0.70 | |
Adj. dividends per share | Rs | 0.55 | 0.56 | 0.59 | 0.66 | 0.67 | |
Avg Dividend yield | % | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
Book value per share (Unadj.) | Rs | 97.7 | 103.6 | 107.9 | 153.2 | 194.4 | |
Adj. book value per share | Rs | 82.6 | 87.5 | 91.2 | 143.7 | 186.5 | |
Shares outstanding (eoy) | m | 3.99 | 3.99 | 3.99 | 4.43 | 4.53 | |
Price / Sales ratio | x | 1.3 | 1.1 | 1.1 | 1.5 | 1.7 | |
Avg P/E ratio | x | 28.5 | 63.2 | 70.3 | 52.2 | 44.1 | |
P/CF ratio (eoy) | x | 22.0 | 31.8 | 35.3 | 38.9 | 35.0 | |
Price / Book Value ratio | x | 3.3 | 2.9 | 3.3 | 4.9 | 5.4 | |
Dividend payout | % | 5.8 | 13.8 | 13.9 | 4.9 | 2.9 | |
Avg Mkt Cap | Rs m | 1,272 | 1,203 | 1,417 | 3,305 | 4,766 | |
Total wages/salary | Rs m | 80 | 89 | 87 | 107 | 115 |
FREDUN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 970 | 1,128 | 1,339 | 2,245 | 2,747 | |
Other income | Rs m | 6 | 5 | 14 | 16 | 18 | |
Total revenues | Rs m | 976 | 1,133 | 1,353 | 2,261 | 2,765 | |
Gross profit | Rs m | 100 | 83 | 82 | 139 | 288 | |
Depreciation | Rs m | 13 | 19 | 20 | 22 | 28 | |
Interest | Rs m | 31 | 45 | 44 | 48 | 104 | |
Profit before tax | Rs m | 62 | 25 | 32 | 86 | 175 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 17 | 6 | 12 | 23 | 67 | |
Profit after tax | Rs m | 45 | 19 | 20 | 63 | 108 | |
Gross profit margin | % | 10.3 | 7.4 | 6.1 | 6.2 | 10.5 | |
Effective tax rate | % | 27.6 | 23.8 | 37.2 | 26.3 | 38.3 | |
Net profit margin | % | 4.6 | 1.7 | 1.5 | 2.8 | 3.9 |
FREDUN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 725 | 1,093 | 1,301 | 1,527 | 2,162 | |
Current liabilities | Rs m | 534 | 860 | 865 | 738 | 1,062 | |
Net working cap to sales | % | 19.7 | 20.7 | 32.6 | 35.2 | 40.1 | |
Current ratio | x | 1.4 | 1.3 | 1.5 | 2.1 | 2.0 | |
Inventory Days | Days | 4 | 4 | 3 | 3 | 3 | |
Debtors Days | Days | 66,900,971 | 126,145,250 | 1,120 | 1,468 | 459 | |
Net fixed assets | Rs m | 324 | 321 | 315 | 343 | 411 | |
Share capital | Rs m | 40 | 40 | 40 | 44 | 45 | |
"Free" reserves | Rs m | 350 | 373 | 391 | 634 | 835 | |
Net worth | Rs m | 390 | 413 | 431 | 678 | 880 | |
Long term debt | Rs m | 106 | 115 | 291 | 420 | 489 | |
Total assets | Rs m | 1,049 | 1,414 | 1,616 | 1,870 | 2,573 | |
Interest coverage | x | 3.0 | 1.6 | 1.7 | 2.8 | 2.7 | |
Debt to equity ratio | x | 0.3 | 0.3 | 0.7 | 0.6 | 0.6 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.8 | 1.2 | 1.1 | |
Return on assets | % | 7.2 | 4.5 | 4.0 | 5.9 | 8.2 | |
Return on equity | % | 11.4 | 4.6 | 4.7 | 9.3 | 12.3 | |
Return on capital | % | 18.7 | 13.2 | 10.5 | 12.2 | 20.3 | |
Exports to sales | % | 42.0 | 30.4 | 33.0 | 32.8 | 22.6 | |
Imports to sales | % | 2.0 | 1.5 | 0.6 | 0.3 | 0.2 | |
Exports (fob) | Rs m | 407 | 343 | 442 | 736 | 620 | |
Imports (cif) | Rs m | 19 | 17 | 7 | 8 | 5 | |
Fx inflow | Rs m | 407 | 343 | 442 | 736 | 620 | |
Fx outflow | Rs m | 19 | 17 | 7 | 8 | 5 | |
Net fx | Rs m | 388 | 326 | 434 | 728 | 615 |
FREDUN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8 | -106 | 2 | -24 | -144 | |
From Investments | Rs m | -53 | -15 | -14 | -41 | -94 | |
From Financial Activity | Rs m | 44 | 137 | -7 | 75 | 252 | |
Net Cashflow | Rs m | 0 | 16 | -19 | 9 | 14 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Daulat N Medhora | COMP SEC: Ankita Joshi | YEAR OF INC: 1987 | BSE CODE: 539730 | FV (Rs): 10 | DIV YIELD (%): 0.1 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare FREDUN PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.